HOME
- About The “New” Prostate Cancer InfoLink
- Polls and surveys
- Who’s using The “New” Prostate Cancer InfoLink? (October 16-23, 2008)
- In the news
- The newsroom
- The “New” Prostate Cancer InfoLink News Blog
- The “New” Prostate Cancer InfoLink Social Network
- Site map
- Copyright
RISK AND PREVENTION
- What is prostate cancer?
- Finding cancer in a man’s prostate is NORMAL!
- Who is at risk for prostate cancer?
- Are all cases of prostate cancer equal in risk?
- Are you taking Propecia (finasteride) for hair loss?
- The PCPT prostate cancer risk calculator
- The Sunnybrook prostate cancer risk calculator
- Projection of prostate cancer risk in Europe
- PSA as a long-term marker for risk
- Prevention: an introduction (with video presentation)
- The importance of exercise and wellness
- The UCSF “healthy lifestyle” score
- Is extract of pomegranate an elixir of life?
- Finasteride and the Prostate Cancer Prevention Trial (PCPT)
- Dutasteride and the REDUCE trial
- The prevention of prostate cancer with 5α-reductase inhibitors (5-ARIs)
- Selenium, vitamin E, and the SELECT trial
- The Physicians Health Study II randomized controlled trial
- The toremifene/PIN prostate cancer prevention trial
DIAGNOSIS
- For newly diagnosed patients …
- Prostate cancer screening and early detection (and video presentation)
- The role of PSA today (in prostate cancer diagnosis)
- Is regular prostate cancer testing appropriate for everyone?
- Prostate cancer screening and the PLCO trial
- Prostate cancer screening and the ERSPC trial
- The Tyrol, Austria and King County, Washington screening studies
- Risk-related screening
- For men over 75: The Iowa Prostate Cancer Consensus
- Signs and symptoms of prostate cancer
- Digital rectal examination or DRE (and video presentation)
- Prostate specific antigen testing
- Diagnosis: an introduction
- Prostate biopsy: how it’s done and what’s involved (and two video presentations)
- Your biopsy results: how to read them and what they mean
- What on Earth is PIN?
- That’s not what ASAP stands for! Is it?
- Other important tests
- The prostatic acid phosphatase or PAP test
- MRI, CT, and other imaging tests
- Bone scans
- Evolving tests for new markers
- The spouse/partner’ roles and perspectives
- Important articles on prostate cancer diagnosis
MANAGEMENT
- In the beginning …
- Staging and grading (with video presentation)
- Treatment: the absolute basics
- The natural history of conservatively treated prostate cancer
- First-line treatments for early stage (localized) disease
- Active surveillance and watchful waiting (with two video presentations)
- Established surgical treatments
- Established radiotherapeutic treatments
- External (photon) beam radiation therapy (EBRT)
- Proton beam radiation therapy (PBRT)
- Permanent implant brachytherapy
- Temporary implant brachytherapy
- Brachytherapy and external beam combination therapies
- Newer forms of radiation therapy
- Stereotactic body radiation therapy (the CyberKnife and RapidArc procedures)
- Other forms of first-line treatment
- Hormone therapy
- Focal therapy for localized prostate cancer: a treatment “in puberty”
- Side effects and complications of first-line therapy: an overview
- The “Quality of Life and Satisfaction with Outcome” study
- Erectile dysfunction (risk, natural history, and management)
- Urinary incontinence
- Painful defecation
- When first-line treatment fails the patient with early stage disease
- Establishing risk and prognosis
- Expectant management (e.g., watchful waiting and active surveillance)
- The role of salvage surgery
- The role of salvage radiation therapy
- The role(s) of hormone therapy
- Investigational forms of salvage therapy
- First-line treatment for non-localized disease
- Active surveillance/watchful waiting
- The role of surgery (surgical debulking)
- External beam radiotherapy
- Hormonal therapies
- Investigational therapies
- Treatment for advanced (non-metastatic) disease
- Hormonal therapies
- Investigational therapies
- The treatment of metastatic disease (and video presentation)
- Active surveillance (watchful waiting)
- Hormonal therapies
- Investigational therapies
- The treatment of hormone-refractory disease
- Anti-androgen withdrawal
- Chemotherapy
- Palliative treatment in late-stage disease
- Management of severe bone pain
- Management of fractures and other complications
- Monitoring treatment: an overview
- The role of PSA tests
- The role of bone scans
- The roles of other tests
- Alternative and complementary medicines
- Side effects and complications of hormonal therapies
- Gynecomastia (swelling and tenderness of the breast)
- Bone loss
- Hot flashes
- Mood changes and depression
- Living with prostate cancer
- Introduction to integrative oncology, by Barrie Cassileth, MS, PhD
- Exercise, wellness, and response to prostate cancer treatment
ASK QUESTIONS
TIPS AND TOOLS
- What cancer cannot do
- Major US-based prostate cancer web sites and organizations
- Major ex-US prostate cancer web sites and organizations
- Us TOO’s suggested on-line prostate cancer resources
- Views from the “other side”: personal reflections about prostate cancer from two urological oncologists
- Tips
- The “top 10” facts you need to know about prostate cancer
- Finding the prostate cancer specialist who is right for YOU
- How to pick a prostate cancer surgeon (by Arnon Krongrad, MD)
- How to select your brachytherapist (by Michael F. Sarosdy, MD)
- Nine tips for picking a radiation oncologist to treat your prostate cancer (by Matthew Katz, MD)
- How to pick a cryotherapy specialist
- Finding the medical oncologist who is right for you: one specialist’s opinion (by Andrew Armstrong, MD, MSc)
- Tools
- Prostate cancer-related abbreviations
- Prognostic tools
- Online prostate cancer management systems
- Finding out about clinical trials
Content of this page last reviewed and updated March 26, 2011